Skip to main content

Text messages can help prevent type 2 diabetes



Text messages that encourage the recipient to eat healthily and exercise can help prevent type 2 diabetes in people at high risk, a study has found. Researchers from Imperial College London and the India Diabetes Research Foundation recruited 537 men in South-East India with impaired glucose tolerance, a condition that commonly precedes type 2 diabetes. Half received frequent text messages reminding them to eat healthily and be physically active, while the other half had standard care from their doctor.

After an average of 20 months’ follow-up, 18 per cent of the text message group developed type 2 diabetes, compared with 27 per cent of the control group. The findings were published in the journal Lancet Diabetes and Endocrinology. The messages included practical tips for healthy eating and reminders about the importance of exercise. They were also tailored to the individual’s behaviour. Those with the most unhealthy lifestyles were given information about the benefits of good habits, such as: “Active life makes you live longer.” Those who followed doctors’ advice were given encouragement to continue, such as: “Hope you had a healthy week!”

Professor Desmond Johnston, from the Department of Medicine at Imperial College London, who led the study, said: “We’ve known for years that you can prevent type 2 diabetes by modifying your lifestyle, but the problem is how to support people to do that. Frequent personal contact with a doctor is effective, but it’s very costly to provide. We’ve shown that you can achieve similar results using mobile phone messaging, which is a very low-cost solution. We plan to carry out more studies in other populations but there’s no reason why this strategy shouldn’t work anywhere else in the world.”

The findings from this research study also have implications for the management of other chronic diseases. Text messaging (SMS) is cheap, quick and simple; and it can also be scaled up to be used in large numbers of people.

The study was funded by the UK India Education and Research Initiative and the World Diabetes Foundation.

Comments

Popular posts from this blog

Improving discharge planning in NHS hospitals

Factors that need to be considered in discharge planning that have been identified in previous projects include:

Ensuring that discharge arrangements are discussed with patients, family members and carers; and that they are given a copy of the discharge summary.Adequate coordination between the hospital, community health services, general practices, and the providers of social care services.There is a follow-up after discharge of patients at high risk of complications or readmission - either in person or by telephone - to ensure that the discharge arrangements are working well. Medicines reconciliation is carried out. This is the process of verifying patient medication lists at a point-of-care transition, such as hospital discharge, to identify which medications have been added, discontinued, or changed from pre-admission medication lists.Ensuring that any outstanding test results at discharge are obtained and passed on to primary care teams; and ensuring there are clear arrangements …

Can GPs issue private prescriptions to NHS patients?

The NHS prescription charge in England is currently £8.40 per item. At this level, many commonly prescribed drugs will cost less than the prescription charge and so some NHS patients may occasionally ask if they can have a private prescription rather than an NHS prescription.

In the past, some GPs have been advised that they could issue both an NHS FP10 and a private prescription, and let the patient decide which to use. But the British Medical Association's General Practice Committee has obtained legal advice that said under the current primary care contract, GPs in England may not issue a private prescription alongside or as an alternative to an NHS FP10 prescription. In any consultation where a GP needs to issue an FP10, the concurrent issue of a private prescription would be a breach of NHS regulations.

The issuing of a private prescription in such circumstances could also be seen as an attempt to deprive the NHS of the funds it would receive from the prescription charge. Fur…

What impact will Brexit have on the UK's life sciences sector?

On Thursday 3 November 2016, I spoke at a seminar at the Imperial College Business School on the topic of the impact of Brexit on the UK's life sciences sector (the NHS, universities, and pharmaceutical and biomedical companies). I emphasised the important role played in the life sciences sector by EU-trained professionals and the need to ensure that the UK continued to attract highly-qualified professionals to work, for example, in our National Health Service. I also discussed the need to increase spending on research and development to ensure that the UK remained a world leader in the biomedical industry. The other speakers at the seminar were Andrew Lansley (former Secretary of State for Health) and Richard Phillips (Director of Healthcare Policy at the Association of British Healthcare industries). The event was chaired by Andrew Brown. A copy of my talk can be viewed on Slideshare.